Tradestie Institutional Equity Comparison Engine
BHST vs HLF โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HLF Overall Edge
HLF Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Herbalife Ltd. (HLF) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BHST trades at N/M Forward P/E with -18.0% operating margin (+3.8% YoY revenue) versus HLF at 5.1x Forward P/E and 9.8% operating margin (+6.0% YoY). In options structure, BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HLF sits in SURGE (4th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
HLF
BHST N/M vs HLF 5.1x Fwd P/E
Growth & Margin Winner
HLF
Op Margin -18.0% vs 9.8% ยท YoY +3.8% vs +6.0%
Momentum & Technical Winner
HLF
1Y -79.4% vs +68.4% ยท 52W Pos 6% vs 58%
Options & Structure Winner
HLF
UNCLASSIFIED (N/A IV) vs SURGE (4th %ile IV)
BHST
NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap
$29.9M
1M Return
-22.62%
1Y Return
-79.4%
Forward P/E
N/M
Unified AI Score
58.2 / 100
HOLD
Tech 75.0
Fund 57.0
Flow 50.0
Mom 60.0
HLF
NYSE
Herbalife Ltd.
Wholesale-Drugs, Proprietaries & Druggists' Sundries
$15.53
-0.26% 1D
Market Cap
$1.6B
1M Return
+12.7%
1Y Return
+68.44%
Forward P/E
5.1x
Unified AI Score
47.4 / 100
HOLD
Tech 31.0
Fund 46.0
Flow 60.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BHST -79.4%
HLF +68.44%
Spread: +147.84 pp (HLF Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | BHST Revenue | HLF Revenue | BHST Op. Margin | HLF Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $4.89B | N/A | 14.0% | HLF |
| FY2019 | N/A | $4.88B | N/A | 11.6% | HLF |
| FY2020 | N/A | $5.54B | N/A | 11.6% | HLF |
| FY2021 | N/A | $5.80B | N/A | 12.7% | HLF |
| FY2022 | N/A | $5.20B | N/A | 10.5% | HLF |
| FY2023 | $10M | $5.06B | -78.6% | 7.0% | HLF |
| FY2024 | $30M | $4.99B | -27.7% | 7.7% | HLF |
| FY2025 | $30M | $5.04B | -16.2% | 9.5% | HLF |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BHST | HLF | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $29.9M | $1.6B | Larger Scale | HLF |
| Trailing P/E Ratio Valuation | N/M | 9.2x | Lower Multiple | HLF |
| Forward P/E Ratio Valuation | N/M | 5.1x | Lower Multiple | HLF |
| Revenue Growth (YoY) Growth | +3.8% | +6.0% | Higher Growth | HLF |
| Operating Margin (TTM) Profitability | -18.0% | 9.8% | Higher Margin | HLF |
| Net Profit Margin Profitability | -31.2% | 3.4% | Higher Margin | HLF |
| Return on Equity (ROE) Capital Efficiency | -142.5% | 0.0% | Higher ROE | HLF |
| 52-Week Range Position Momentum | 6% ($1โ$7) | 58% ($9โ$20) | Stronger Trend | HLF |
| Beta / 30D Volatility Risk Regime | 0.25ฮฒ ยท 86% Vol | 1.02ฮฒ ยท 50% Vol | Lower Realized Risk | HLF |
| Unified Institutional Score Composite Signal | 58.2 / 100 (HOLD) | 47.4 / 100 (HOLD) | Higher Composite | BHST |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BHST vs HLF Buy Guide
BHST
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
HLF
SURGE
5d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
4th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BHST nor HLF registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.